<?xml version="1.0" encoding="utf-8"?>
<!-- generator="FeedCreator 1.8.0-dev (info@mypapit.net)" -->
<rss version="2.0"  xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title></title>
        <description></description>
        <link>http://www.xendo.com/</link>
        <lastBuildDate>Wed, 22 Feb 2012 18:41:43 GMT</lastBuildDate>
        <generator>FeedCreator 1.8.0-dev (info@mypapit.net)</generator>
		<atom:link href="http://www.xendo.com/component/option,com_ninjarsssyndicator/feed_id,7/format,raw/" rel="self" type="application/rss+xml" />        <item>
            <title>Collaboration Batavia and Xendo</title>
            <link>http://www.xendo.com/EN/News/Collaboration-Batavia-and-Xendo.html</link>
            <description><![CDATA[Business Collaboration Batavia Bioservices BV and Xendo BV
Leiden, August 25, 2011Today Batavia Bioservices BV and Xendo BV announce that they have initiated a strategic business collaboration. As a consequence, all Bioprocess activities of Xendo Manufacturing BV have been transferred to Batavia Bioservices BV.

Read more... (http://www.xendo.com/EN/News/Collaboration-Batavia-and-Xendo.html)]]></description>
            <pubDate>Thu, 25 Aug 2011 09:50:47 GMT</pubDate>
            <guid isPermaLink="false">http://www.xendo.com/EN/News/Collaboration-Batavia-and-Xendo.html</guid>
        </item>
        <item>
            <title>New CEO</title>
            <link>http://www.xendo.com/EN/News/New-CEO.html</link>
            <description><![CDATA[New CEO
Xendo announces the appointment of André van de Sande as new CEO Leiden, The Netherlands, 1st of February 2011
Xendo has appointed André van de Sande MBA as the new CEO for all its activities related to Xendo BV, Xendo Pharma Services BV, Xendo Manufacturing BV and Xendo Deutschland GmbH.

Read more... (http://www.xendo.com/EN/News/New-CEO.html)]]></description>
            <pubDate>Thu, 16 Dec 2010 08:33:59 GMT</pubDate>
            <guid isPermaLink="false">http://www.xendo.com/EN/News/New-CEO.html</guid>
        </item>
        <item>
            <title>New website</title>
            <link>http://www.xendo.com/EN/News/New-website.html</link>
            <description><![CDATA[New Website
Xendo has gone through a number of changes in the last year, such as the sale of our clinical activities to QPS and the internal restructuring of the Xendo Leiden organization. We are now ready for all future challenges and a new website is the reflection of this towards the outside world.

Read more... (http://www.xendo.com/EN/News/New-website.html)]]></description>
            <pubDate>Thu, 16 Dec 2010 08:33:59 GMT</pubDate>
            <guid isPermaLink="false">http://www.xendo.com/EN/News/New-website.html</guid>
        </item>
        <item>
            <title>QPS Announces the Acquisition of Xendo Drug Development</title>
            <link>http://www.xendo.com/EN/News/QPS-Announces-the-Acquisition-of-Xendo-Drug-Development.html</link>
            <description><![CDATA[QPS Announces the Acquisition of Xendo Drug Development
FOR IMMEDIATE RELEASE:
QPS Announces the Acquisition of Xendo Drug DevelopmentThis European Acquisition Expands QPS’ Global Capabilities

Read more... (http://www.xendo.com/EN/News/QPS-Announces-the-Acquisition-of-Xendo-Drug-Development.html)]]></description>
            <pubDate>Mon, 26 Jul 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.xendo.com/EN/News/QPS-Announces-the-Acquisition-of-Xendo-Drug-Development.html</guid>
        </item>
        <item>
            <title>Medische Technologie meets Life Science</title>
            <link>http://www.xendo.com/EN/News/Medische-Technologie-meets-Life-Science.html</link>
            <description><![CDATA[Medische Technologie meets Life Science
Medical Delta Cafe:  Medische Technologie meets Life Science

Read more... (http://www.xendo.com/EN/News/Medische-Technologie-meets-Life-Science.html)]]></description>
            <pubDate>Tue, 08 Jun 2010 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.xendo.com/EN/News/Medische-Technologie-meets-Life-Science.html</guid>
        </item>
        <item>
            <title>Dutch inspection tightens control</title>
            <link>http://www.xendo.com/EN/News/Dutch-inspection-tightens-control.html</link>
            <description><![CDATA[Dutch inspection tightens control
 
Dutch inspection tightens control on management of medical technology in hospitals           

Read more... (http://www.xendo.com/EN/News/Dutch-inspection-tightens-control.html)]]></description>
            <pubDate>Wed, 25 Mar 2009 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.xendo.com/EN/News/Dutch-inspection-tightens-control.html</guid>
        </item>
        <item>
            <title>Xendo's Integrated Drug Development concept accelerates biopharmaceutical development projects</title>
            <link>http://www.xendo.com/EN/News/Xendo-s-Integrated-Drug-Development-concept-accelerates-biopharmaceutical-development-projects.html</link>
            <description><![CDATA[Xendo's Integrated Drug Development concept accelerates biopharmaceutical development projects
 
Xendo has joined forces  with Selexis S.A. and now offers the biopharmaceutical industry their  newly developed Integrated Drug Development concept.  

Read more... (http://www.xendo.com/EN/News/Xendo-s-Integrated-Drug-Development-concept-accelerates-biopharmaceutical-development-projects.html)]]></description>
            <pubDate>Fri, 14 Nov 2008 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.xendo.com/EN/News/Xendo-s-Integrated-Drug-Development-concept-accelerates-biopharmaceutical-development-projects.html</guid>
        </item>
        <item>
            <title>Disposables Reach Out to New Markets</title>
            <link>http://www.xendo.com/EN/News/Disposables-Reach-Out-to-New-Markets.html</link>
            <description><![CDATA[Disposables Reach Out to New Markets
8 October 2007
Development and Application of Single-use Products Is Expanding Throughout Industry
There is no denying the growing usage of disposables—only three  percent of biopharmaceutical manufacturers claim to use none, according  to a report by BioPlan Associates.

Read more... (http://www.xendo.com/EN/News/Disposables-Reach-Out-to-New-Markets.html)]]></description>
            <pubDate>Mon, 08 Oct 2007 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.xendo.com/EN/News/Disposables-Reach-Out-to-New-Markets.html</guid>
        </item>
        <item>
            <title>Xendo partner in Top Institute Pharma</title>
            <link>http://www.xendo.com/EN/News/Xendo-partner-in-Top-Institute-Pharma.html</link>
            <description><![CDATA[Xendo partner in Top Institute Pharma
15 november 2006


Technological  Top Institute (TTI) is an efficient and internationally acclaimed  instrument to increase the impact of public/private cooperation in  R&amp;D. FIGON, the Netherlands Federation for Innovative Drug Research,  has led the initiative to obtain commitments of both industrial and  academic partners to participate in a new Top Institute Pharma, which  became effective late 2005.

Read more... (http://www.xendo.com/EN/News/Xendo-partner-in-Top-Institute-Pharma.html)]]></description>
            <pubDate>Wed, 15 Nov 2006 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.xendo.com/EN/News/Xendo-partner-in-Top-Institute-Pharma.html</guid>
        </item>
    </channel>
</rss>

